The natural history of infection with the lymphadenopathy-associated virus/human T-lymphotropic virus type III
- PMID: 2996406
- DOI: 10.7326/0003-4819-103-5-719
The natural history of infection with the lymphadenopathy-associated virus/human T-lymphotropic virus type III
Abstract
Over half of the persons infected with the lymphadenopathy-associated virus/human T-lymphotropic virus type III (LAV/HTLV-III), the retrovirus that causes the acquired immunodeficiency syndrome (AIDS), become persistently infected with the virus. These "carriers" serve as the major reservoir of infection for others. Virus from their vascular and lymphatic spaces infects others through direct blood or mucous membrane exposure. After months to years, a high proportion of those infected will develop clinical manifestations of infection. For infected homosexual men, approximately 25% have developed AIDS-related conditions, mainly lymphadenopathy, and approximately 10% have developed AIDS. Because of the large number of infected persons in the United States, increasing rates of disease can be expected.
Similar articles
-
Persistent infection of chimpanzees with human T-lymphotropic virus type III/lymphadenopathy-associated virus: a potential model for acquired immunodeficiency syndrome.J Virol. 1986 Apr;58(1):116-24. doi: 10.1128/JVI.58.1.116-124.1986. J Virol. 1986. PMID: 3005641 Free PMC article.
-
Persistent infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in apparently healthy homosexual men.Ann Intern Med. 1985 May;102(5):627-8. doi: 10.7326/0003-4819-102-5-627. Ann Intern Med. 1985. PMID: 2984973
-
Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in human T lymphotropic virus-III positive individuals with symptoms of acquired immunodeficiency syndrome and in a patient with acquired immunodeficiency syndrome.J Clin Invest. 1985 Oct;76(4):1699-704. doi: 10.1172/JCI112158. J Clin Invest. 1985. PMID: 2997287 Free PMC article.
-
Infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus: considerations for transmission in the child day care setting.Rev Infect Dis. 1986 Jul-Aug;8(4):606-12. doi: 10.1093/clinids/8.4.606. Rev Infect Dis. 1986. PMID: 3018893 Review.
-
The epidemiology and prevention of the acquired immunodeficiency syndrome.Ann Intern Med. 1985 Nov;103(5):657-62. doi: 10.7326/0003-4819-103-5-657. Ann Intern Med. 1985. PMID: 2996395 Review.
Cited by
-
Human immunodeficiency virus infection in multi-transfused patients with thalassaemia major.Eur J Pediatr. 1988 Apr;147(3):304-7. doi: 10.1007/BF00442701. Eur J Pediatr. 1988. PMID: 3391224
-
Human immunodeficiency virus 1. Predominance of a group-specific neutralizing epitope that persists despite genetic variation.J Exp Med. 1989 Nov 1;170(5):1681-95. doi: 10.1084/jem.170.5.1681. J Exp Med. 1989. PMID: 2478654 Free PMC article.
-
Evidence for a Euro-American origin of human immunodeficiency virus (HIV).J Natl Med Assoc. 1987 Oct;79(10):1068-72. J Natl Med Assoc. 1987. PMID: 3316673 Free PMC article. Review.
-
Practical management of common AIDS-related medical problems.West J Med. 1987 Feb;146(2):237-40. West J Med. 1987. PMID: 3825129 Free PMC article. No abstract available.
-
Selective alterations in immunoregulatory lymphocyte subsets in early HIV (human T-lymphotropic virus type III/lymphadenopathy-associated virus) infection.J Clin Immunol. 1987 Mar;7(2):140-50. doi: 10.1007/BF00916008. J Clin Immunol. 1987. PMID: 2883197
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
